| Effects of counterion structure on the surface activities of anionic fluorinated surfactants whose counterions are organic ammonium ions AT Gao, H Xing, HT Zhou, AQ Cao, BW Wu, HQ Yu, ZM Gou, JX Xiao Colloids and Surfaces A: Physicochemical and Engineering Aspects 459, 31-38, 2014 | 17 | 2014 |
| Abnormal surface-active behavior of perfluorooctanoates induced by salt HT ZHOU, AT GAO, H XING, ZM GOU, JX XIAO Acta Chimica Sinica 69 (9), 1035, 2011 | 11 | 2011 |
| Breath biomarkers associated with nontuberculosis mycobacteria disease status in persons with cystic fibrosis: a pilot study A Mani-Varnosfaderani, A Gao, KR Poch, SM Caceres, JA Nick, JE Hill Journal of Breath Research 16 (3), 031001, 2022 | 8 | 2022 |
| The role of nascn on the equimolar cationic–anionic surfactant mixtures: Evidence from nmr, surface tension and dynamic light scattering HT Zhou, SS Lin, H Xing, AT Gao, JX Xiao Colloids and Surfaces A: Physicochemical and Engineering Aspects 416, 16-22, 2013 | 6 | 2013 |
| Volatile sputum biomarkers can monitor the response to treatment of nontuberculous mycobacteria disease: a pilot study A Gao, A Mani-Varnosfaderani, K Poch, S Caceres, J Nick, J Hill CMBES Proceedings 45, 2023 | 2 | 2023 |
| Headspace Solid-Phase Micro-Extraction Method Optimization and Evaluation for the Volatile Compound Extraction of Bronchoalveolar Lung Lavage Fluid Samples A Gao, N Nouri, K Stevenson, ET Zemanick, JA Nick, JE Hill Separations 11 (1), 27, 2024 | 1 | 2024 |
| 165: Volatile metabolites are novel, noninvasive markers of nontuberculosis mycobacteria infection and disease status in the cystic fibrosis airway A Mani-Varnosfaderani, J Hill, A Gao, L Kang, J Nick, K Poch Journal of Cystic Fibrosis 20, S82, 2021 | 1 | 2021 |
| 135 Detection of nontuberculous mycobacteria abscessus and phage treatment response using volatile biomarkers A Gao, J Nick, M Cristinziano, G Hatfull, K Poch, S Caceres, A Mani, ... Journal of Cystic Fibrosis 23, S73-S74, 2024 | | 2024 |
| 132 Detection of nontuberculous mycobacterial disease using volatile biomarkers A Gao, J Nick, K Poch, S Caceres, A Mani, B Vestal, J Hill Journal of Cystic Fibrosis 23, S71-S72, 2024 | | 2024 |
| 138 Prospective standardized assessment of people with cystic fibrosis and nontuberculous mycobacteria pulmonary disease undergoing treatment with bacteriophage: design and … J Nick, S Martiniano, V Lovell, B Vestal, K Poch, S Caceres, N Rysavy, ... Journal of Cystic Fibrosis 23, S75-S76, 2024 | | 2024 |
| 42 Volatile organic compounds distinguish Mycobacterium avium from Mycobacterium abscessus in cystic fibrosis sputum samples A Gao, A Mani-Varnosfaderani, L Kang, K Poch, S Caceres, J Nick, J Hill Journal of Cystic Fibrosis 22, S22-S23, 2023 | | 2023 |
| 530 Airway volatile organic compounds can achieve culture-independent identification of Nontuberculous mycobacteria in people with cystic fibrosis A Mani-Varnosfaderani, A Gao, L Kang, J Nick, K Poch, J Hill Journal of Cystic Fibrosis 21, S296, 2022 | | 2022 |
